Home


About Fortimedix Surgical

Fortimedix Surgical is a fast growing medical device company with the ambition to inspire a new wave of technological advancement in the field of minimally invasive surgery. The company is headquartered in Nuth, The Netherlands, and has a US subsidiary in San Diego, CA. With a strong history as a global market leader in contract stent manufacturing, Fortimedix has been a trusted partner in the medical device industry for over 15 years. Read more about Fortimedix Surgical.

"It is very exciting to be part of this new wave of technological advancement across surgical specialties.."

Santiago Horgan, MD
UC San Diego School of Medicine

 

"It is very exciting
to be part of inspiring
a new wave of technological
advancement across
 surgical specialties."

Santiago Horgan, MD
UC San Diego School of Medicine


About symphonX™

symphonX™ is the world’s first single-port surgery solution compatible with a standard 15mm laparoscopic trocar. Emulating conventional, multi-port laparoscopy enables surgeons to perform procedural steps ergonomically, allowing a comfortable and secure single-port approach. symphonX™ is poised to deliver on the promise of single-port surgery, including fewer port-site complications, less post-operative pain, exceptional cosmesis, elevating the standard of care in laparoscopy. Read more about symphonX™.


symphonX™ successfully launched at the ACS Clinical Congress 2016 in Washington, DC

During the Clinical Congress 2016 of the American College of Surgeons in October, Fortimedix Surgical successfully launched its innovative symphonX™ Surgical Platform in the U.S. Throughout the four-day event, we received overwhelmingly positive feedback from the surgical community, underlining the need for a single-port surgery solution that is easy-to-use and compatible with a standard 15mm trocar. Follow the updates on this website as we continue to introduce symphonX™ in key markets around the world.

By using our website you consent to all cookies in accordance with our Cookie Policy.